Companies / Sutro Biopharma, Inc.

Sutro Biopharma, Inc.

Nasdaq: STROCIK 1382101SOUTH SAN FRANCISCO, CAsutrobio.com ↗

Financials · FY2025

Revenue$102.48M
Net income$-191.09M
Total debt$8.12M
Cash$54.34M
Diluted EPS$-22.49
Shares outstanding16.6M

Ownership

16.6M shares outstanding · as of Aug 7, 2026
0.21%Insiders
Ownership
Insiders0.21%35,528
10%+ / strategic5.26%872,558
Institutions61.46%10,191,380
Public float33.06%5,481,705

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 12

View all →
Insider% of sharesShares
Chung JaneCEOChief Executive Officer · Director
0.13%21,285
Pauling DavidFormerChief Admin. Ofcr. & GC
0.06%9,748
Gerber Hans-PeterCHIEF SCIENTIFIC OFFICER
0.06%9,518
Chow Gregory K.CFO
0.03%4,725
Dybbs MichaelDirector
——
Hunter HeidiDirector
——
Jagpal SukhiDirector
——
Lobacki Joseph MDirector
——
Matsui ConnieDirector
——
Panek James PDirector
——

Institutional holders 74

View all →
HolderValue% of shares
BlackRock, Inc.$37.27M6.77%
Bvf INC/IL$31.18M7.55%
Orbimed Advisors LLC$19.96M4.83%
RA Capital Management, L.P.$17.82M4.31%
Perceptive Advisors LLC$17.82M4.31%
Balyasny Asset Management L.P.$11.60M2.81%
State Street Corporation$10.16M1.85%
Merck & Co., Inc.$9.04M1.64%
Affinity Asset Advisors, LLC$8.66M4.51%
Kynam Capital Management, LP$5.55M2.89%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 2, 2026Chung Jane
CEO
OtherCommon Stock$57.1K-3K
-11.80%
20,779
0.13% of shares
low
Mar 1, 2026Chung Jane
CEO
OtherCommon Stock$26.0K-1K
-7.44%
15,808
0.10% of shares
low
Mar 2, 2026Gerber Hans-Peter
Executive
OtherCommon Stock$24.0K-1K
-10.95%
9,518
0.06% of shares
low
Mar 2, 2026Pauling David
Executive
OtherCommon Stock$19.9K-970
-9.40%
9,350
0.06% of shares
low
Mar 1, 2026Pauling David
Executive
OtherCommon Stock$11.3K-551
-6.47%
7,964
0.05% of shares
low
Mar 1, 2026Gerber Hans-Peter
Executive
OtherCommon Stock$9.5K-463
-5.57%
7,845
0.05% of shares
low
Mar 4, 2026Chung Jane
CEO
OtherCommon Stock$6.0K-282
-1.31%
21,285
0.13% of shares
low
Mar 4, 2026Pauling David
Executive
OtherCommon Stock$5.9K-277
-2.76%
9,748
0.06% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Affinity Asset Advisors, LLCPassive13G/A———
Suvretta Capital Management, LLCPassive13G/A———
Suvretta Capital Management, LLCPassive13G/A———
Biotechnology Value Fund L PPassive13G———
Perceptive Advisors LLCPassive13G———
Millennium Management LLCPassive13G/A———
Affinity Asset Advisors, LLCPassive13G/A———
Kynam Capital Management, LPPassive13G/A—872,558—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
STRO——869367102—
STRO——869367201—